<DOC>
	<DOC>NCT00240032</DOC>
	<brief_summary>This study is designed to compare injection skin (injection site) reactions when an antihistamine (Zyrtec®) or placebo is taken prior to performing daily Copaxone® injections. Patients will be assigned (like a flip of a coin) to take either a placebo or an antihistamine (Zyrtec®) prior to performing their daily Copaxone® injections. The patient and physician will be unaware whether they are taking a placebo or antihistamine during the study.</brief_summary>
	<brief_title>A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Histamine Antagonists</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>Male or female 18 years of age or older Diagnosis of RRMS Beginning or recently (within &lt; 3months) began selfinjecting Copaxone® Taking any other immunomodulatory therapy in conjunction with Copaxone® Unable to perform subcutaneous selfinjection Pregnant or trying to become pregnant, or breast feeding during the study Previously participated in this study or in another clinical trial in the past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>